U.S., May 31 -- ClinicalTrials.gov registry received information related to the study (NCT06996574) titled 'Study to Compare the Clinical Effectiveness and Cost Utility of an All-in-one Procedure With an At-home Screening Trial' on May 06.
Brief Summary: In 2019, the Dutch Healthcare Institute published a consensus report outlining when spinal cord stimulation (SCS) for chronic pain qualifies for reimbursement under Dutch health insurance. It mandates that adult patients with significant pain (VAS >=50mm or NRS >=5) undergo an at-home screening trial, which must show at least 50% pain reduction to proceed with permanent implantation. While screening trials allow patients to experience the therapy beforehand, they are costly, duplicative, a...